Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 12/20 | 0.51 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21551228 | 0.90 | FURIN (0.52) | FURINGPR119NPC1RAB9AKMT2A | |
| SCHEMBL26077217 | 0.88 | FURIN (0.52) | FURINGPR119ALDH1A1TSHRNPSR1 | |
| SCHEMBL26077211 | 0.88 | FURIN (0.52) | FURINGPR119ALDH1A1TSHRNPSR1 | |
| SCHEMBL26077220 | 0.86 | GPR119 (0.51) | FURINGPR119NPC1RAB9AKMT2A | |
| SCHEMBL30931809 | 0.86 | FURIN (0.48) | FURINGPR119 | |
| SCHEMBL21551215 | 0.86 | FURIN (0.48) | FURINGPR119 | |
| SCHEMBL29891361 | 0.86 | FURIN (0.48) | FURINGPR119 | |
| SCHEMBL26077248 | 0.85 | RAB9A (0.43) | FURINCNR2NPC1RAB9AKMT2A | |
| SCHEMBL26077351 | 0.85 | FURIN (0.44) | FURINGPR119CNR2NPC1RAB9A | |
| SCHEMBL26077377 | 0.85 | FURIN (0.39) | FURINGPR119NPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773078-B2 | Furin inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773078-B2 | Furin inhibitors | FURIN, TGFB1, PCSK7 | FURIN 1/4885GPR119 2318/4885CNR2 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.